EGFR T790M mutation testing within the osimertinib AURA Phase I study

Dearden, S; Brown, H; Jenkins, S; Thress, KS; Cantarini, M; Cole, R; Ranson, M; Janne, PA

Dearden, S (reprint author), AstraZeneca, Bldg 310,Cambridge Sci Pk, Cambridge CB04 0WG, England.

LUNG CANCER, 2017; 109 ( ): 9